Auriga Reiterates a 'Buy' on Medidata Solutions (MDSO); A "Clinical Force" to be Reckoned With
Tweet Send to a Friend
Auriga reiterates a 'Buy' on Medidata Solutions (NASDAQ: MDSO), raises PT to $33.
Auriga analyst says, "Medidata's annual analyst event ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "Medidata's annual analyst event ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
